Supportive therapy in hemato-oncology
Supportive therapy in Oncology
Nausea and vomiting caused by chemotherapy and radiation therapy can significantly affect the quality of life of cancer patients. It usually occurs in up to 30% of patients within the first 72-96 hours after the administration of chemotherapy and is one of the most common side effects. It is very important to prevent nausea and vomiting with optimal drugs during each cycle of chemotherapy. New antiemetics usually prevent acute and delayed nausea and vomiting caused by chemotherapy. Therefore, it is of utmost importance to have the most effective antiemetics for the treatment of chemotherapy-induced nausea.
Conditioning Treatment for Bone Marrow Transplant (BMT)
The BMT, or blood stem cell transplant, it’s a procedure that infuses healthy blood-forming stem cells into the body to replace bone marrow which is damaged and is no longer able to produce healthy blood cells. BMT can treat more than 100 serious diseases, which can be cancerous and non-cancerous, and is used in patients with hematological, immune, or neoplastic disorders, such as leukemias, lymphomas, and immunodeficiencies.
Before BMT, a preparative or conditioning treatment is performed to destroy diseased cells in the bone marrow, eliminate the disease, and make room for the new, healthy blood stem cells that will be received.
Two conditioning methods are used for preparation:
Chemotherapy with radiotherapy, being highly invasive, and therapy with alkylating drugs, the latter being minimally invasive.
Stendhal entered the market with an original product that has extensive clinical development and more than 20 years of experience with hemato-oncologist doctors for the conditioning of patients candidates for BMT.
